These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
243 related items for PubMed ID: 24554304
1. Use of eltrombopag for the treatment of thrombocytopenia in hypoplastic myelodysplastic syndrome. Gauchan D, Shaaban H, Gedeon D, Maroules M. Ann Hematol; 2014 Oct; 93(10):1777-8. PubMed ID: 24554304 [No Abstract] [Full Text] [Related]
2. Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial. Oliva EN, Alati C, Santini V, Poloni A, Molteni A, Niscola P, Salvi F, Sanpaolo G, Balleari E, Germing U, Fenaux P, Stamatoullas A, Palumbo GA, Salutari P, Impera S, Avanzini P, Cortelezzi A, Liberati AM, Carluccio P, Buccisano F, Voso MT, Mancini S, Kulasekararaj A, Morabito F, Bocchia M, Cufari P, Spiriti MA, Santacaterina I, D'Errigo MG, Bova I, Zini G, Latagliata R. Lancet Haematol; 2017 Mar; 4(3):e127-e136. PubMed ID: 28162984 [Abstract] [Full Text] [Related]
3. Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial. Platzbecker U, Wong RS, Verma A, Abboud C, Araujo S, Chiou TJ, Feigert J, Yeh SP, Götze K, Gorin NC, Greenberg P, Kambhampati S, Kim YJ, Lee JH, Lyons R, Ruggeri M, Santini V, Cheng G, Jang JH, Chen CY, Johnson B, Bennett J, Mannino F, Kamel YM, Stone N, Dougherty S, Chan G, Giagounidis A. Lancet Haematol; 2015 Oct; 2(10):e417-26. PubMed ID: 26686043 [Abstract] [Full Text] [Related]
4. Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial. Mittelman M, Platzbecker U, Afanasyev B, Grosicki S, Wong RSM, Anagnostopoulos A, Brenner B, Denzlinger C, Rossi G, Nagler A, Garcia-Delgado R, Portella MSO, Zhu Z, Selleslag D. Lancet Haematol; 2018 Jan; 5(1):e34-e43. PubMed ID: 29241762 [Abstract] [Full Text] [Related]
5. Successful platelet count recovery in lupus-associated thrombocytopenia with the thrombopoietin agonist eltrombopag. Scheinberg P, Singulane CC, Barbosa LS, Scheinberg M. Clin Rheumatol; 2014 Sep; 33(9):1347-9. PubMed ID: 24740463 [Abstract] [Full Text] [Related]
8. Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia. Violi F, Pignatelli P. N Engl J Med; 2012 Nov 22; 367(21):2056. PubMed ID: 23171115 [No Abstract] [Full Text] [Related]
9. Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia. Lisman T, Porte RJ. N Engl J Med; 2012 Nov 22; 367(21):2055-6. PubMed ID: 23171114 [No Abstract] [Full Text] [Related]